Profile: Ocera Therapeutics, Inc. focuses on the development of therapeutics in the areas of liver and gastrointestinal diseases. Our OCR-002 is an injectable product for the treatment of acute hepatic encephalopathy in patients with liver cirrhosis and acute liver failure. Our AST-120 is a microspherical carbon adsorbent with selective adsorption profile for a variety of unwanted substances in the digestive tract.